1.00
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Fangzhou
Its shares trade on HKEX under the ticker 6086.HK. It has been listed since 9 July 2024. In the fiscal year to 31 December 2025, it reported revenue of CN¥4.12bn and net income of CN¥13.8m. At that date it held total assets of CN¥950.6m and shareholders' equity of CN¥179.6m.
Fangzhou Inc is a CN-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2024-07-09. Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The firm operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 9 Jul 2024
- Employees
- 515
- Website
- investors.jianke.com ↗
Leadership
Pay as last reported
- Mr. Fangmin XieExecutive Chairman of the Board, Chief Executive Officer, since 2015CN¥6.7m
- Mr. Yuming ZouChief Financial Officer, Executive Director, Joint Company Secretary, since 2018CN¥1.8m
- Mr. Feng ZhouExecutive Director, Chief Strategy Officer, since 2015CN¥4.2m
- Mr. David HandNon-Executive Director
- Ms. Wei KangNon-Executive Independent Director
- Dr. Haizhong WangNon-Executive Independent Director
- Mr. Xiaolu ZhuNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Fangzhou Inc employs 515 full-time employees in Guangzhou, CN.
- The company operates three segments including Comprehensive Medical Services and Online Retail Pharmacy.
- Fangzhou Inc provides online chronic disease management services with e-prescriptions and home delivery.
Weaknesses
- Fangzhou Inc has only one listed date on 9 July 2024, which is recent.
- The company's business is limited to Consumer Staples Distribution & Retail industry.
- Fangzhou Inc's segments are focused on online services without physical stores.
Opportunities
- Fangzhou Inc can expand its Customized Content and Marketing Solutions segment in the CN market.
- The company can leverage its Online Retail Pharmacy Services for growing healthcare demand in CN.
- Fangzhou Inc may grow its Comprehensive Medical Services segment through partnerships in Guangzhou.
Threats
- Fangzhou Inc faces competition from established players in CN's Consumer Staples sector.
- The company's reliance on online services may be impacted by internet regulations in CN.
- Fangzhou Inc's recent IPO on 9 July 2024 may lead to market volatility.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.